Antibiotics in the clinical pipeline at the end of 2015

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of antibiotics (Tokyo. 1968)

• Publication date

  2016-06-29

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/ja.2016.72PMID 27353164
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Discovery and development of surotomycin for the treatment of Clostridium difficile

  2016cited by this paper
• Alternatives to antibiotics-a pipeline portfolio review.

  2016cited by this paper
• Impact of Surotomycin on the Gut Microbiota of Healthy Volunteers in a Phase 1 Clinical Trial

  2016cited by this paper
• In vitro antimicrobial activity of S-649266, a catechol-substituted siderophore cephalosporin, when tested against non-fermenting Gram-negative bacteria.

  2016cited by this paper
• TBA-354 : A new drug for the treatment of persistent tuberculosis

  2015cited by this paper
• The antibiotic resistance crisis: part 2: management strategies and new agents.

  2015cited by this paper
• Nonmedical Uses of Antibiotics: Time to Restrict Their Use?

  2015cited by this paper
• Structure-Activity Relationship of the Aminomethylcyclines and the Discovery of Omadacycline

  2015cited by this paper
• OP0595, a new diazabicyclooctane: mode of action as a serine β-lactamase inhibitor, antibiotic and β-lactam 'enhancer'.

  2015cited by this paper
• Delamanid for Extensively Drug-Resistant Tuberculosis.

  2015cited by this paper
• Effects of Surotomycin on Clostridium difficile Viability and Toxin Production In Vitro

  2015cited by this paper
• High Efficacy of Finafloxacin on Helicobacter pylori Isolates at pH 5.0 Compared with That of Other Fluoroquinolones

  2015cited by this paper
• Erratum: A new antibiotic kills pathogens without detectable resistance

  2015cited by this paper
• Zabofloxacin versus moxifloxacin in patients with COPD exacerbation: a multicenter, double-blind, double-dummy, randomized, controlled, Phase III, non-inferiority trial

  2015cited by this paper
• In vitro bactericidal activity of aminoglycosides, including the next-generation drug plazomicin, against Brucella spp.

  2015cited by this paper
• Antimicrobial resistance in humans, livestock and the wider environment

  2015cited by this paper
• Plazomicin: an investigational therapy for the treatment of urinary tract infections

  2015cited by this paper
• Tackling the threat of antimicrobial resistance: from policy to sustainable action

  2015cited by this paper
• In Vitro Antimicrobial Activity of a Siderophore Cephalosporin, S-649266, against Enterobacteriaceae Clinical Isolates, Including Carbapenem-Resistant Strains

  2015cited by this paper
• In Vitro Activity of Cefepime/AAI101 and Comparators against Cefepime Non-susceptible Enterobacteriaceae

  2015cited by this paper
• A new antibiotic kills pathogens without detectable resistance

  2015cited by this paper
• In Vitro Activity of Ceftolozane Alone and in Combination with Tazobactam against Extended-Spectrum-β-Lactamase-Harboring Enterobacteriaceae

  2015cited by this paper
• Mode of Action and Bactericidal Properties of Surotomycin against Growing and Nongrowing Clostridium difficile

  2015cited by this paper
• Oxa, Thia, Heterocycle, and Carborane Analogues of SQ109: Bacterial and Protozoal Cell Growth Inhibitors.

  2015cited by this paper
• A community-based approach to new antibiotic discovery

  2015cited by this paper
• ESKAPEing the labyrinth of antibacterial discovery

  2015cited by this paper
• Safety, tolerability and pharmacokinetics of AFN-1252 administered as immediate release tablets in healthy subjects.

  2015cited by this paper
• In Vivo Activities of Simulated Human Doses of Cefepime and Cefepime-AAI101 against Multidrug-Resistant Gram-Negative Enterobacteriaceae

  2015cited by this paper
• Development of new antibiotics: taking off finally?

  2015cited by this paper
• Tedizolid: The First Once-Daily Oxazolidinone Class Antibiotic.

  2015cited by this paper
• Eravacycline (TP-434) Is Active In Vitro against Biofilms Formed by Uropathogenic Escherichia coli

  2015cited by this paper
• Delafloxacin, a non-zwitterionic fluoroquinolone in Phase III of clinical development: evaluation of its pharmacology, pharmacokinetics, pharmacodynamics and clinical efficacy.

  2015cited by this paper
• Surveillance of antibiotic resistance

  2015cited by this paper
• Helping Chemists Discover New Antibiotics.

  2015cited by this paper
• The antibiotic resistance crisis: part 1: causes and threats.

  2015cited by this paper
• Antimicrobial resistance: addressing the threat to global health. Preface.

  2015cited by this paper
• Mutations in Genes for the F420 Biosynthetic Pathway and a Nitroreductase Enzyme Are the Primary Resistance Determinants in Spontaneous In Vitro-Selected PA-824-Resistant Mutants of Mycobacterium tuberculosis

  2015cited by this paper
• Structure-Activity Relationship Studies of a Series of Semisynthetic Lipopeptides Leading to the Discovery of Surotomycin, a Novel Cyclic Lipopeptide Being Developed for the Treatment of Clostridium difficile-Associated Diarrhea.

  2015cited by this paper
• The drug push.

  2015cited by this paper
• Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI).

  2015cited by this paper
• Pharmacodynamic Profile of GSK2140944 against Methicillin-Resistant Staphylococcus aureus in a Murine Lung Infection Model

  2015cited by this paper
• Mining the microbial dark matter

  2015cited by this paper
• Activity of Debio1452, a FabI Inhibitor with Potent Activity against Staphylococcus aureus and Coagulase-Negative Staphylococcus spp., Including Multidrug-Resistant Strains

  2015cited by this paper
• Ceftolozane/Tazobactam

  2015cited by this paper
• Finafloxacin: First Global Approval

  2015cited by this paper
• The livestock reservoir for antimicrobial resistance: a personal view on changing patterns of risks, effects of interventions and the way forward

  2015cited by this paper
• The new tuberculosis drug Perchlozone® shows cross-resistance with thiacetazone.

  2015cited by this paper
• The potential role of nemonoxacin for treatment of common infections

  2015cited by this paper
• Antibiotic resistance breakers: can repurposed drugs fill the antibiotic discovery void?

  2015cited by this paper
• BEAM to fight antimicrobial resistance

  2015cited by this paper
• SMT19969 for Clostridium difficile infection (CDI): in vivo efficacy compared with fidaxomicin and vancomycin in the hamster model of CDI

  2015cited by this paper
• The global challenge of new classes of antibacterial agents: an industry perspective.

  2015cited by this paper
• SQ109, a New Drug Lead for Chagas Disease

  2015cited by this paper
• Inhibition of Neisseria gonorrhoeae Type II Topoisomerases by the Novel Spiropyrimidinetrione AZD0914*

  2015cited by this paper
• Delafloxacin, a non-zwitterionic fluoroquinolone in Phase III of clinical development: evaluation of its pharmacology, pharmacokinetics, pharmacodynamics and clinical efficacy

  2015cited by this paper
• Editorial overview: Anti-infectives: Current challenges and unmet needs in antimicrobial therapy.

  2015cited by this paper
• AFN‐1252 is a potent inhibitor of enoyl‐ACP reductase from Burkholderia pseudomallei—Crystal structure, mode of action, and biological activity

  2015cited by this paper
• Tedizolid: A Novel Oxazolidinone with Potent Activity Against Multidrug-Resistant Gram-Positive Pathogens

  2015cited by this paper
• Confronting the challenges of discovery of novel antibacterial agents.

  2014cited by this paper
• Therapeutic strategies to combat antibiotic resistance.

  2014cited by this paper
• LTX-109 Is a Novel Agent for Nasal Decolonization of Methicillin-Resistant and -Sensitive Staphylococcus aureus

  2014cited by this paper
• Delamanid: A Review of Its Use in Patients with Multidrug-Resistant Tuberculosis

  2014cited by this paper
• Selection and characterisation of Staphylococcus aureus mutants with reduced susceptibility to the investigational oxazolidinone MRX-I.

  2014cited by this paper
• New potent antibacterial oxazolidinone (MRX-I) with an improved class safety profile.

  2014cited by this paper
• Second MRSA antibiotic reaches the market

  2014cited by this paper
• The Antimicrobial Resistance Crisis: Causes, Consequences, and Management

  2014cited by this paper
• Absorption, Distribution, Metabolism, and Excretion of the Novel Antibacterial Prodrug Tedizolid Phosphate

  2014cited by this paper
• Anti-cooperative ligand binding and dimerisation in the glycopeptide antibiotic dalbavancin

  2014cited by this paper
• In Vivo Antibacterial Activity of MRX-I, a New Oxazolidinone

  2014cited by this paper
• Carbapenem-Resistant Klebsiella pneumoniae Strains Exhibit Diversity in Aminoglycoside-Modifying Enzymes, Which Exert Differing Effects on Plazomicin and Other Agents

  2014cited by this paper
• Update on the antibiotic resistance crisis.

  2014cited by this paper
• High In Vitro Activity of the Novel Spiropyrimidinetrione AZD0914, a DNA Gyrase Inhibitor, against Multidrug-Resistant Neisseria gonorrhoeae Isolates Suggests a New Effective Option for Oral Treatment of Gonorrhea

  2014cited by this paper
• Antibiotic resistance sweeping developing world

  2014cited by this paper
• Novel Insights into the Mechanism of Inhibition of MmpL3, a Target of Multiple Pharmacophores in Mycobacterium tuberculosis

  2014cited by this paper
• In Vitro and In Vivo Activities of the Nitroimidazole TBA-354 against Mycobacterium tuberculosis

  2014cited by this paper
• Determination of Disk Diffusion and MIC Quality Control Guidelines for GSK2140944, a Novel Bacterial Type II Topoisomerase Inhibitor Antimicrobial Agent

  2014cited by this paper
• Contribution of the Nitroimidazoles PA-824 and TBA-354 to the Activity of Novel Regimens in Murine Models of Tuberculosis

  2014cited by this paper
• Multicenter, Double-Blind, Randomized, Phase II Trial To Assess the Safety and Efficacy of Ceftolozane-Tazobactam plus Metronidazole Compared with Meropenem in Adult Patients with Complicated Intra-Abdominal Infections

  2014cited by this paper
• Nemonoxacin: First Global Approval

  2014cited by this paper
• In vitro activity of the siderophore monosulfactam BAL30072 against contemporary Gram-negative pathogens from New York City, including multidrug-resistant isolates.

  2014cited by this paper
• Alectinib: A Review of Its Use in Advanced ALK-Rearranged Non-Small Cell Lung Cancer

  2014cited by this paper
• 256S-649266, a Novel Siderophore Cephalosporin: Mechanisms of enhanced activity and beta-lactamase stability

  2014cited by this paper
• β-Lactam Antibiotics Renaissance

  2014cited by this paper
• Crystalline β- lactamase inhibitor

  2014cited by this paper
• Lead optimization of a novel series of imidazo[1,2-a]pyridine amides leading to a clinical candidate (Q203) as a multi- and extensively-drug-resistant anti-tuberculosis agent.

  2014cited by this paper
• Fraunhofer to mine Sanofi microbial collection

  2014cited by this paper
• In Vitro Activity of Plazomicin against 5,015 Gram-Negative and Gram-Positive Clinical Isolates Obtained from Patients in Canadian Hospitals as Part of the CANWARD Study, 2011-2012

  2014cited by this paper
• Glycopeptide antibiotics: Back to the future

  2014cited by this paper
• In Vitro Activity of the New Fluoroketolide Solithromycin (CEM-101) against Macrolide-Resistant and -Susceptible Mycoplasma genitalium Strains

  2014cited by this paper
• Why emergency management should be interested in the emergence of antibiotic resistance

  2014cited by this paper
• Pharmacokinetics, pharmacodynamics and efficacy of novel FabI inhibitor AFN-1252 against MSSA and MRSA in the murine thigh infection model

  2013cited by this paper
• Investigations of the Mode of Action and Resistance Development of Cadazolid, a New Antibiotic for Treatment of Clostridium difficile Infections

  2013cited by this paper
• A Novel Macrolide Solithromycin Exerts Superior Anti-inflammatory Effect via NF-κB Inhibition

  2013cited by this paper
• Locations of the hydrophobic side chains of lipoglycopeptides bound to the peptidoglycan of Staphylococcus aureus.

  2013cited by this paper
• Antibiotics in the clinical pipeline in 2013

  2013cited by this paper
• N-Chloramines, a Promising Class of Well-Tolerated Topical Anti-Infectives

  2013cited by this paper
• Involvement of Fe Uptake Systems and AmpC β-Lactamase in Susceptibility to the Siderophore Monosulfactam BAL30072 in Pseudomonas aeruginosa

  2013cited by this paper
• In vitro activity of cadazolid against Clostridium difficile strains isolated from primary and recurrent infections in Stockholm, Sweden.

  2013cited by this paper
• New β‐lactam–β‐lactamase inhibitor combinations in clinical development

  2013cited by this paper
• Antisense battles small molecule for slice of rare lipid disorder market

  2013cited by this paper

• Cyclic Diguanylate G-Quadruplex Inducer-Siderophore Hybrids as Bifunctional Antibiofilm Agents against Pseudomonas aeruginosa.

  2026cites this paper
• Design and Synthesis of several new developed Sulfa Drugs and screening of  their Antimicrobial and Antifungal  Activities

  2026cites this paper
• Verification and application of an automated real-time antimicrobial susceptibility testing system: for accelerated antibiotic susceptibility testing and high-throughput screening of antibiotic synergistic effects.

  2026cites this paper
• Nanobiotics to tackle efflux-mediated resistance in bacterial pathogens.

  2025cites this paper
• vB_PaeP_PZH3, a novel bacteriophage for the treatment of MDR Pseudomonas aeruginosa in a mouse wound infection model.

  2025cites this paper
• Engineering Streptomyces coelicolor for heterologous expression of the thiopeptide GE2270A—A cautionary tale

  2025cites this paper
• Synthesis and biological activity evaluation of a novel pleuromutilin derivative 22-((2-methyl-1-(1H-pyrrole-2-carboxamido)propan-2-yl)thio)-deoxypleuromutilin

  2025cites this paper
• Design and Production of Geranylated Cyclic Peptides by the RiPP Enzymes SyncM and PirF

  2025cites this paper
• Winners of the 2024 JA Ōmura Awards for excellence

  2025cites this paper
• An anti-virulence drug targeting the evolvability protein Mfd protects against infections with antimicrobial resistant ESKAPE pathogens

  2025cites this paper
• Design, synthesis, and bioactivity of newly potent pleuromutilin derivatives.

  2025cites this paper
• Challenges of Carbapenem-Resistant Enterobacteriaceae in the Development of New β-Lactamase Inhibitors and Antibiotics

  2025cites this paper
• Stepwise antibacterial strategy for orthopedic implants using bacteriophages on electrospun cefiderocol/PCl/Gt nanofibers over PEO-coated Mg3ZnCa

  2025cites this paper
• Antibiotics re-booted—time to kick back against drug resistance

  2025cites this paper
• Addressing antimicrobial resistance by using macrocyclic peptides

  2025cites this paper
• Search for Antibiotic Producers Among Actimycetes Isolated from the Salt Lake Bolshoi Tambukan (Northern Caucasus)

  2025cites this paper
• An Evaluation of the Impact of an OPEN Stewardship Generated Feedback Intervention on Antibiotic Prescribing among Primary Care Veterinarians in Canada and Israel

  2024cites this paper
• Application of 18β-glycyrrhetinic acid in the structural modification of natural products: a review

  2024cites this paper
• Synthesis and Characterization of Functionalized Starch by Grafting Pyridine for Use in Antimicrobial Applications

  2024cites this paper
• Photodynamic Therapy of LD4-Photosensitizer Attenuates the Acute Pneumonia Induced by Klebsiella pneumoniae.

  2024cites this paper
• Fragment Discovery by X‐Ray Crystallographic Screening Targeting the CTP Binding Site of Pseudomonas Aeruginosa IspD

  2024cites this paper
• Whole Cell Luminescence-Based Screen for Inhibitors of the Bacterial Sec Machinery

  2024cites this paper
• Preparation of Biocompatible Antimicrobial Polymer Embedded with Ricinoleic Acid

  2024cites this paper
• Intracellular Quantification of an Antibiotic Metal Complex in Single Cells of Escherichia coli Using Cryo-X-ray Fluorescence Nanoimaging

  2024cites this paper
• Design, Synthesis and Activity Against Drug‐Resistant Bacteria Evaluation of 1H‐Pyrazole‐[3,4‐b] Pyridine Derivatives

  2024cites this paper
• High-throughput screening identification of apigenin that reverses the colistin resistance of mcr-1-positive pathogens

  2024cites this paper
• 4-[(E)-2-(1-Pyrenyl)Vinyl]Pyridine Complexes: How to Modulate the Toxicity of Heavy Metal Ions to Target Microbial Infections

  2024cites this paper
• Single Modification at the N‐Terminus of Norvancomycin to Combat Drug‐Resistant Gram‐Positive Bacteria

  2023cites this paper
• Antibacterial activity of human natural killer cells in the absence of accessory cells against extracellular Staphylococcus aureus and hypervirulent Pseudomonas aeruginosa bacteria

  2023cites this paper
• Anisotropy in Antimicrobial Bottle Brush Copolymers and Its Influence on Biological Activity

  2023cites this paper
• Discovery of novel tetrahydrobenzothiophene derivatives as MSBA inhibitors for antimicrobial agents.

  2023cites this paper
• Elucidating the Mechanism of Action of the Gram-Negative-Pathogen-Selective Cyclic Antimicrobial Lipopeptide Brevicidine

  2023cites this paper
• Real‐Time Monitoring of Multitarget Antimicrobial Mechanisms of Peptoids Using Label‐Free Imaging with Optical Diffraction Tomography

  2023cites this paper
• High-Throughput Screening of Natural Product and Synthetic Molecule Libraries for Antibacterial Drug Discovery

  2023cites this paper
• Medical Students' Understanding, Attitudes, and Awareness of Antibiotic Resistance

  2023cites this paper
• Application of Antimicrobial Peptides as Diagnostic Biosensors

  2023cites this paper
• Antioxidant, Antimicrobial, and Insecticidal Properties of Chemically Characterized Essential Oils Extracted from Mentha longifolia: In Vitro and In Silico Analysis

  2023cites this paper
• PHT427 as an effective New Delhi metallo-β-lactamase-1 (NDM-1) inhibitor restored the susceptibility of meropenem against Enterobacteriaceae producing NDM-1

  2023cites this paper
• Exploring halophilic environments as a source of new antibiotics

  2023cites this paper
• Dual Action of Eeyarestatin 24 on Sec-Dependent Protein Secretion and Bacterial DNA

  2023cites this paper
• A 2.8 Å Structure of Zoliflodacin in a DNA Cleavage Complex with Staphylococcus aureus DNA Gyrase

  2023cites this paper
• Phosphine chalcogenides and their derivatives from red phosphorus and functionalized pyridines, imidazoles, pyrazoles and their antimicrobial and cytostatic activity.

  2023cites this paper
• Structural Study of Potent Triazole-Based Inhibitors of Staphylococcus aureus Biotin Protein Ligase.

  2023cites this paper
• Infective Endocarditis due to Non-HACEK Gram-Negative Bacilli: Clinical Characteristics and Risk Factors from a Prospective Multicenter Brazilian Cohort

  2023cites this paper
• -Aryl-2(trifluoromethyl)benzo[][1,8]naphthyridin-4(1)-one as Convenient Platform to Design High Photostable and Long-Lived Dyad Fluorophore with Potential Application in Live-Cell Imaging

  2023cites this paper
• Novel xanthone antibacterials: Semi-synthesis, biological evaluation, and the action mechanisms.

  2023cites this paper
• Recent Advances in Strategies to Combat Bacterial Drug Resistance: Antimicrobial Materials and Drug Delivery Systems

  2023cites this paper
• Simultaneous control of infection and inflammation with keratin-derived antibacterial peptides targeting TLRs and co-receptors

  2023cites this paper
• Search for Novel Halophilic and Halotolerant Producers of Antimicrobial Compounds in Various Extreme Ecosystems

  2023cites this paper
• Antibiotics in the clinical pipeline as of December 2022

  2023influential citation
• COMPARATIVE ASSESSMENT OF ANTIBACTERIAL AND ANTIFUNGAL ACTIVITIES OF METALLIC ION BASED FORMULATIONS

  2023cites this paper
• Transformable nano-antibiotics for mechanotherapy and immune activation against drug-resistant Gram-negative bacteria

  2023cites this paper
• Development of Antibiofilm Therapeutics Strategies to Overcome Antimicrobial Drug Resistance

  2022cites this paper
• Synthesis, Antibacterial Activity, and Nephrotoxicity of Polymyxin B Analogues Modified at Leu-7, d-Phe-6, and the N-Terminus Enabled by S-Lipidation.

  2022cites this paper
• Uncovering the biodiversity and biosynthetic potentials of rare actinomycetes

  2022cites this paper
• Antibiotics needed to treat multidrug-resistant infections in neonates

  2022cites this paper
• A 2.8 Å structure of zoliflodacin in a DNA-cleavage complex with Staphylococcus aureus DNA gyrase

  2022cites this paper
• Evaluation of the Antimicrobial Activity in Host-Mimicking Media and In Vivo Toxicity of Antimicrobial Polymers as Functional Mimics of AMPs

  2022cites this paper
• Novel antimicrobial activity of protein produced by Streptomyces lividans TK24 against the phytopathogen Clavibacter michiganensis

  2022cites this paper
• Synthesis and In Vitro Antimicrobial Evaluation of New Quinolone Based 2-Arylamino Pyrimidines

  2022cites this paper
• Exploration of Chemical Biology Approaches to Facilitate the Discovery and Development of Novel Antibiotics

  2022cites this paper
• Identification of 5-(Aryl/Heteroaryl)amino-4-quinolones as Potent Membrane-Disrupting Agents to Combat Antibiotic-Resistant Gram-Positive Bacteria.

  2022cites this paper
• Bacteriophage therapy as an alternative technique for treatment of multidrug-resistant bacteria causing diabetic foot infection

  2022cites this paper
• Design, characterization and structure–function analysis of novel antimicrobial peptides based on the N-terminal CATH-2 fragment

  2022influential citation
• Insights into applications and strategies for discovery of microbial bioactive metabolites.

  2022cites this paper
• Synthesis and Biological Evaluation of 3-(Pyridine-3-yl)-2-Oxazolidinone Derivatives as Antibacterial Agents

  2022cites this paper
• Multifunctional Tetracycline-Loaded Silica-Coated Core-Shell Magnetic Nanoparticles: Antibacterial, Antibiofilm, and Cytotoxic Activities.

  2022cites this paper
• Mechanisms of Antimicrobial Resistance: Highlights on Current Advance Methods for Detection of Drug Resistance and Current Pipeline Antitubercular Agents.

  2022cites this paper
• Design, synthesis and antibacterial activity of novel pleuromutilin derivatives with thieno[2,3-d]pyrimidine substitution.

  2022cites this paper
• Library Screening for Synergistic Combinations of FDA-Approved Drugs and Metabolites with Vancomycin against VanA-Type Vancomycin-Resistant Enterococcus faecium

  2022cites this paper
• Traditional Screening and Genome-Guided Screening of Natural Products from Actinobacteria

  2022cites this paper
• Antioxidant and Antimicrobial Activities of Chemically-Characterized Essential Oil from Artemisia aragonensis Lam. against Drug-Resistant Microbes

  2022cites this paper
• Synthesis and biological evaluation of novel N, N'-diarylurea derivatives as potent antibacterial agents against MRSA.

  2022cites this paper
• Design, synthesis, and biological evaluation of tetrahydroquinoline amphiphiles as membrane-targeting antimicrobials against pathogenic bacteria and fungi.

  2022cites this paper
• Natural-Product-Directed Catalytic Stereoselective Synthesis of Functionalized Fused Borane Cluster–Oxazoles for the Discovery of Bactericidal Agents

  2022cites this paper
• Antimicrobial Properties and the Effect of Temperature on the Formation of Secondary Metabolites in Psychrophilic Micromycetes

  2022cites this paper
• Investigations into the membrane activity of arenicin antimicrobial peptide AA139.

  2022cites this paper
• Structure-Based Rational Design of Small α-Helical Peptides with Broad-Spectrum Activity against Multidrug-Resistant Pathogens

  2022cites this paper
• Comparative genomics with evolutionary lineage in Streptomyces bacteria reveals high biosynthetic potentials

  2022cites this paper
• Brevicidine, a bacterial non-ribosomally produced cyclic antimicrobial lipopeptide with a unique modus operandi

  2022cites this paper
• Phytotoxicity and Antimicrobial Activity of Green Synthesized Silver Nanoparticles Using Nigella sativa Seeds on Wheat Seedlings

  2022cites this paper
• Synergistic Combinations of FDA-Approved Drugs with Ceftobiprole against Methicillin-Resistant Staphylococcus aureus

  2022cites this paper
• The antimicrobial potential of cannabidiol

  2021cites this paper
• Evaluation of an OPEN Stewardship generated feedback intervention to improve antibiotic prescribing among primary care veterinarians in Ontario, Canada and Israel: protocol for evaluating usability and an interrupted time-series analysis

  2021cites this paper
• Recent advances in antibacterial agents.

  2021cites this paper
• Antimicrobial peptides as a potent therapeutic regimen to quench biofilm-mediated antimicrobial resistance

  2021cites this paper
• Bacteriophages Against Pathogenic Bacteria and Possibilities for Future Application in Africa

  2021cites this paper
• Polymeric approach to combat drug-resistant methicillin-resistant Staphylococcus aureus

  2021cites this paper
• Simultaneous Control of Infection and Inflammation by Keratin-Derived Antibacterial Peptides (KAMPs) Targeting TLRs and Co-Receptors

  2021cites this paper
• Antimicrobial Potential of the Alkalophilic Fungus Sodiomyces alkalinus and Selection of Strains–Producers of New Antimicotic Compound

  2021cites this paper
• Layered double hydroxides-silver-chlorin e6 nanocomposite for photo-chemo combination therapy to efficiently combat both Gram-positive and Gram-negative bacteria

  2021cites this paper
• Antibacterial activities of the chemical constituents of Schizophyllum commune MST7-3 collected from coal area

  2021cites this paper
• Bactericidal Activity of Multilayered Hybrid Structures Comprising Titania Nanoparticles and CdSe Quantum Dots under Visible Light

  2021cites this paper
• Antibacterial Combinations

  2021cites this paper
• The development of three ruthenium-based antimicrobial metallodrugs: Design, synthesis, and activity evaluation against Staphylococcus aureus

  2021cites this paper
• Short Peptides and Their Mimetics as Potent Antibacterial Agents and Antibiotic Adjuvants.

  2021cites this paper
• Phenylindolylmethyldiaminopyrimidines (PIDAPs) as Potent Antimicrobials Against Staphylococcus Aureus

  2021cites this paper
• Cationic Antimicrobial Peptides Are Leading the Way to Combat Oropathogenic Infections.

  2021cites this paper
• Insights into the Variation in Bioactivities of Closely Related Streptomyces Strains from Marine Sediments of the Visayan Sea against ESKAPE and Ovarian Cancer

  2021cites this paper
• The cell-free system: A new apparatus for affordable, sensitive, and portable healthcare

  2021cites this paper